Intco Medical Hits Day High with Strong 3.14% Intraday Surge

Intco Medical Technology Co., Ltd. has experienced a notable increase of 3.14% on July 10, 2026, reaching an intraday high of CNY 46.36. This performance stands in contrast to the broader market, as the China Shanghai Composite index declined by 1.0% on the same day. Over the past week, Intco Medical has shown a robust gain of 9.42%, further highlighting its recent upward momentum. Despite the positive short-term performance, the company has faced challenges in profitability, reporting a net profit of CNY 68.84 million, which reflects a significant decline of 63.33% over the last three quarters. The return on equity (ROE) stands at 3.08%, and the company has a high debt-equity ratio of 26.41%, indicating a leveraged position. In terms of valuation, Intco Medical's price-to-book ratio is 1.19, suggesting it may be considered expensive relative to its book value. The stock has generated a remarkable return of 71.13% over the past year, although profits have decreased by 58.1% during the same period. The company maintains a dividend yield of 0.33%, which may attract income-focused investors.